Silence Therapeutics (United Kingdom)

Silence Therapeutics (United Kingdom)

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Silence Therapeutics (United Kingdom), United Kingdom, covering academic research published from 2001 to 2024. Read More.


Open Access Percentage

60%


Total
Publications

111


Total Open
Publications

67


Total
Citations

2.7K


Open Access
Percentage

60%


Total
Publications

111


Total Open
Publications

67


Total
Citations

2.7K

Wikipedia

Website

download

Breakdown

17% 38% 5% 40%

Publisher Open

17%

Both

38%

Other Platform Open

5%

Closed

40%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

28%OA Journal

OA Journal 28%

17

Hybrid 33%

20

No Guarantees 39%

24

Other Platform Open

Domain 81%

39

Institution 38%

18

Public 13%

6

Preprint 8%

4

Other Internet 6%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
38
Europe PMC
Domain
16
Figshare
Public
15
University of East Anglia - UEA Digital Repository
Institution
3
Radboud University - Radboud Repository
Institution
3
University of Cambridge - Apollo
Institution
2
University of Bristol - Bristol Research
Institution
2
University College London - UCL Discovery
Institution
2
Imperial College London - Spiral
Institution
2
DOI
Other Internet
2
1 / 3

Data updated 7 April 2025

Share

Share

Share